Clinical Trial of YuWell YE660D Blood Pressure Monitor in General Population According to the ISO 81060-2:2018
Validation of the YuWell YE660D Oscillometric Upper-arm Blood Pressure Monitor for Clinic and Home in General Population According to the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018)
1 other identifier
interventional
92
1 country
1
Brief Summary
The purpose of this study is to evaluate the accuracy of the YuWell YE660D oscillometric upper-arm blood pressure monitor for clinic and home in general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2022
CompletedMarch 10, 2022
March 1, 2022
6 months
June 12, 2021
March 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure measurement data
Systolic Pressure and Diastolic Pressure
30 minutes
Study Arms (1)
YuWell YE660D and mercury sphygmomanometer
EXPERIMENTALBlood Pressure Measurement with the YuWell YE660D Electronic Sphygmomanometer (YuWell YE660D) and with Desk Mercury Sphygmomanometer.
Interventions
Measurement blood pressure by YuWell YE660D Electronic Sphygmomanometer and Desk Mercury Sphygmomanometer
Eligibility Criteria
You may qualify if:
- Years and older;
- Subjects voluntarily participate in the clinical trial and sign the informed consent.
You may not qualify if:
- Disturbance of consciousness;
- Patients requiring hemodialysis;
- Taking anticoagulant drugs due to cardiovascular and cerebrovascular diseases;
- Pregnant and lactating women;
- Patients with cardiac arrhythmias;
- Other conditions that the investigator considers ineligible for clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
Study Officials
- STUDY DIRECTOR
Mingzhi Long, MD,PHD
The Second Hospital of Nanjing Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical Trial Center
Study Record Dates
First Submitted
June 12, 2021
First Posted
June 18, 2021
Study Start
September 1, 2021
Primary Completion
March 1, 2022
Study Completion
March 8, 2022
Last Updated
March 10, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share